dorzolamide hydrochloride

This page contains recent news articles, when available, and an overview of dorzolamide hydrochloride but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

… Tentative Approval for Dorzolamide Hydrochloride with Timolol...  -  Apr 10, 2008
Hi-Tech's dorzolamide hydrochloride with timolol maleate ophthalmic solution is the generic equivalent of Merck's Cosopt(R) and is indicated for the ... Genetic Engineering News - Genetic Engineering News (press release)

… -Free Glaucoma Treatment Cosopt (dorzolamide hydrochloride/timolol ...  -  Nov 3, 2005
Preservative-free dorzolamide hydrochloride/timolol maleate answers an important medical need. All other glaucoma treatments currently approved in Canada ... DG News

… Generic Forms of Dorzolamide Hydrochloride-Timolol Maleate and …  -  Oct 28, 2008
Prasco to Distribute Generic Forms of Dorzolamide Hydrochloride-Timolol Maleate and Dorzolamide Hydrochloride Ophthalmic Solutions (Comparable to Merck's ... Pay-Per-View - PR Newswire - HighBeam Research

… - Tentative Approval For Dorzolamide Hydrochloride With Timolol...  -  Apr 14, 2008
Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that the US Food and Drug Administration (FDA) has granted tentative approval to the Company's ... Medical News Today - Medical News Today (press release)

Prasco Laboratories Pictures from October 28, 2008 | HighBeam …  -  Oct 28, 2008
Dorzolamide Hydrochloride-Timolol Maleate Ophthalmic Solution & Dorzolamide Hydrochloride Ophthalmic Solution (Photo: Business Wire). ... Pay-Per-View - AP Images - HighBeam Research

Study Demonstrates Benefits of Combination Treatment for Glaucoma  -  May 11, 2006
Cosopt® contains two active ingredients, dorzolamide hydrochloride and timolol maleate, that have been demonstrated to reduce pressure inside the eye caused ... DG News

Woman referred for pressure in left eye  -  Sep 15, 2006
Eye drops in the left eye included prednisolone acetate 1% four times a day (for post-laser inflammation), dorzolamide hydrochloride-timolol maleate twice a ... OSN SuperSite

Hi-Tech Pharmacal Co.  -  Sep 29, 2008
Hi-Tech's dorzolamide hydrochloride with timolol maleate ophthalmic solution is the generic equivalent of Merck & Co.'s Cosopt and is indicated for the ... $9.94 - Chain Drug Review - Alacra Store

Hi-Tech Pharmacal Co.(RX/GENERIC DRUGS--Profiles)(Hi-Tech …  -  Sep 29, 2008
Hi-Tech's dorzolamide hydrochloride with timolol maleate ophthalmic solution is the generic equivalent of Merck & Co.'s Cosopt and is indicated for the ... Pay-Per-View - Chain Drug Review - HighBeam Research

Volumetric colour Doppler imaging: a useful tool for the determination...  -  Jun 3, 2005
Trusopt ® contains 22.26 mg dorzolamide hydrochloride per 1 ml. Further ingredients of Trusopt ® are hydroxyethylcellulose, D-mannitol, sodium citrate, ... Nature.com

Fixed-combination solution reduces IOP at all time points: dorzolamide...  -  Sep 1, 2007
Application of the fixed combination ophthalmic solution 2% dorzolamide hydrochloride/0.5% timolol maleate (Cosopt, Merck, Sharp & Dohme) resulted in a ... Free with registration - Ophthalmology Times - AccessMyLibrary.com

The effects of dorzolamide 2% and dorzolamide/timolol fixed combinatio...  -  Jan 18, 2008
Purpose To compare the effect of dorzolamide hydrochloride 2%, timolol maleate 0.5%, and their fixed combination on intraocular pressure (IOP) and retinal ... Nature.com

Dorzolamide May Be Effective, Well Tolerated for Pediatric Glaucoma  -  Sep 13, 2005
..."The topical carbonic anhydrase inhibitor dorzolamide hydrochloride (Trusopt; Merck & Co, Inc, Whitehouse Station, NJ) has been studied in pediatric ... Medscape

IP Think Tank Global Week In Review.(reports of intellectual property)  -  Dec 5, 2007
Cosopt (dorzolamide hydrochloride and timolol maleate) - Merck achieves dismissal of invalidity claims & thwarts Apotex's chance at 180 d exlusivity: ... Free with registration - Mondaq Business Briefing - AccessMyLibrary.com

Pharmacology; Novel dorzolamide formulation has improved …  -  Apr 22, 2005
In their study, "dorzolamide hydrochloride was formulated as 2% and 4% low viscosity solutions (viscosity 3-5 cps) containing randomly methylated ... Pay-Per-View - Drug Week - Factiva, from Dow Jones

IP Think Tank Global Week In Review.  -  Dec 5, 2007
Cosopt (dorzolamide hydrochloride and timolol maleate) - Merck achieves dismissal of invalidity claims & thwarts Apotex's chance at 180 d exlusivity: ... $9.94 - Mondaq Business Briefing - Alacra Store

IP Think Tank Global Week In Review.(reports of intellectual property)  -  Dec 5, 2007
Cosopt (dorzolamide hydrochloride and timolol maleate) - Merck achieves dismissal of invalidity claims & thwarts Apotex's chance at 180 d exlusivity: ... $4.95 - Mondaq Business Briefing - ECNext

Long Island Medical Briefs: April 25, 2008  -  Apr 25, 2008
The drug, dorzolamide hydrochloride with timolol maleate, is the equivalent of drugmaker Merck's Cosopt, which had sales of $334 million in 2007. ... $2.95 - Long Island Business News - NewsBank

Press Release: A Comprehensive Competitor Close-Up for Merck & …  -  Dec 4, 2008
...and Cosopt/Trusopt (dorzolamide hydrochloride; ophthalmic) in October 2008. Merck is taking aggressive action to counteract its challenges. ... Pay-Per-View - M2 Presswire - HighBeam Research





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy